[Diagnosis and management of alcohol-use disorders]
- PMID: 24954172
- DOI: 10.1016/j.encep.2014.05.001
[Diagnosis and management of alcohol-use disorders]
Abstract
With the publication of the DSM-5, the alcoholic disease becomes Alcohol-use disorders taking into account dependence and damages according to a gradient of severity. This conceptual evolution should improve the screening of people affected by this chronic and progressive disease associated with a heavy impact on morbidity and mortality. This identification is provided by the clinical interview and examination. Its sensitivity can be improved by questionnaires and biological markers. Damage and related pathologies have to be systematically revealed. In this context, the MoCA test allows the early detection of cognitive disorders. Care management aims for a change in consumption and consists in supporting the patient in his/her approach. Care management should be personalized, appropriated to the patient's informed choice and graded according to disorders' severity. This includes a psychosocial intervention which can be associated with drugs. Abstinence is no longer the only alternative: decreasing consumption with the aim of regulation has been shown interesting in the reduction of harmful consumption. When therapeutic withdrawal turns out to be necessary, use of a treatment should not be systematic. If necessary, benzodiazepines remain the first-line treatment with a limited duration of prescription. According to his/her profile, the patient can receive a long-term treatment to help to maintain abstinence, prevent relapse or reduce consumption. There is evidence that identifying and involving patients in their care significantly improve their health. Effective treatments are available for treating alcohol-use disorders. However, only a relatively small number of patients receive specific management appropriated to their needs and according to concrete goals.
Keywords: Chronic and progressive disease; Consommation régulée; Maladie chronique évolutive; Personalized care; Prevent relapse; Prise en charge personnalisée; Prévention de la rechute; Reduce consumption; Repérage; Réduction des dommages; Screening.
Copyright © 2014 L’Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Secondary benefits of cognitive rehabilitation for a chronic ethylic patient: effects on disorder consciousness, motivation, and global therapeutic cooperation].Encephale. 2014 Jun;40(3):263-70. doi: 10.1016/j.encep.2013.03.007. Epub 2013 Aug 5. Encephale. 2014. PMID: 23928068 French.
-
[Management of alcohol use disorders in ambulatory care: Which follow-up and for how long?].Encephale. 2016 Feb;42(1):67-73. doi: 10.1016/j.encep.2015.12.010. Epub 2016 Jan 13. Encephale. 2016. PMID: 26796554 Review. French.
-
[Early detection, negotiation and treatment of alcohol use disorders in primary care].Dtsch Med Wochenschr. 2014 May;139(18):943-52; quiz 953-6. doi: 10.1055/s-0034-1369832. Epub 2014 Apr 23. Dtsch Med Wochenschr. 2014. PMID: 24760716 German.
-
[Alcohol consumption in patients with psychiatric disorders: assessment and treatment].Encephale. 2014 Sep;40(4):301-7. doi: 10.1016/j.encep.2014.07.008. Epub 2014 Aug 8. Encephale. 2014. PMID: 25113419 Review. French.
-
[Epidemiologic warnings from studies on alcohol use disorders].Encephale. 2014 Apr;40(2):129-35. doi: 10.1016/j.encep.2014.02.005. Epub 2014 Mar 14. Encephale. 2014. PMID: 24631427 French.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials